HPA Contributes To Vital Infection Research
The Health Protection Agency is a contributor to two research consortia who have been granted a total of Euro 9million by the UK Clinical Research Collaboration (UKCRC) to carry out crucial research into microbiology and infectious diseases. The two consortia are based in London and Oxford.
The Oxford consortium comprises the Oxford Biomedical Research Centre (a partnership between the Oxford Radcliffe Hospitals and the University of Oxford), the Health Protection Agency, and the Wellcome Trust Sanger Institute. The Consortia will focus on research to increase understanding of how infectious diseases are transmitted with the aim of improving control of their spread
The London consortium is based at Imperial College London. It will focus on research into individual and organisational behavioural change, modelling, epidemiology, rapid diagnosis and surveillance of selected infectious diseases to address the challenge of healthcare-associated infection. It will bring together clinical, laboratory, public health, academic and managerial research expertise to drive forward translational and applied research on infection. The overall aim is to embed infection control into healthcare delivery.
Dr Christine McCartney Director of the Regional Microbiology Network, whose Division is taking the lead on this work for the Agency said, “We are delighted to be a part of both of these consortia and will be providing all our skills and expertise in microbiology to ensure they are a success.
We will be contributing to the essential research carried out by these consortia which will help to modernise microbiology and to further develop our microbiological skills to their best effect to protect patients from infectious diseases. The London consortium will be looking in particular at healthcare associated infections and how we can work with the NHS to reduce hospital infection and make the delivery of healthcare safer for patients”
The UKCRC Translational Infection Research Initiative is a partnership of seven funders who have committed up to Euro16.5m investment to strengthen infection research in the UK. The Partners are: the Biotechnology and Biological Sciences Research Council; the Medical Research Council; the National Institute for Health Research; the Northern Ireland Health and Social Care Research and Development Office; the Chief Scientist Office of the Scottish Government Health Directorates; the Wales Office of Research and Development for Health and Social Care, Welsh Assembly Government; and the Wellcome Trust.